Loading…

Ostem Implant announced it will merge Topplan, its wholly owned subsidiary in implant development and manufacturing, effective January 1, 2025. The merger ratio is 1:0 as Ostem Implant owns 100% of Topplan. Topplan will continue as a separate business department within Ostem Implant.
“Ostem Implant announced on the 11th that it will merge Topplan, a subsidiary of implant development and manufacturing”mk.co.kr
Summarized from public sources; check the original articles before acting on it.